CAS: 637328-69-9; Tanogitran

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      📜(R)-2-(4-Amidinophenylaminomethyl)-1-Methyl-5-[1-(Ethyloxycarbonylmethylamino)-1-(Pyrrolidinocarbonyl)-Ethyl]-Benzimidazole-P-Toluenesulphonic Acid Salt置于氢氧化钾,对甲苯磺酸体系中,用 甲醇 作为反应溶剂,化学反应 2.5H,以85%的收率获得产物tanogitran; N-[(1R)-1-[2-[[(4-甲脒基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]-1-甲基-2-氧代-2-(1-吡咯烷基)乙基]甘氨酸
      参考文献:(R) 2-(4-Amidinophenylaminomethyl)-1-Methyl-5-[1-(Carboxymethylamino)-1 (Pyrrolidinocarbonyl)-Ethyl]-Benzimidazole,The Monohydrochloride Thereof,Preparation Thereof And The Use As Pharmaceutical Composition
      标题:(R) 2-(4-Amidinophenylaminomethyl)-1-Methyl-5-[1-(Carboxymethylamino)-1 (Pyrrolidinocarbonyl)-Ethyl]-Benzimidazole,The Monohydrochloride Thereof,Preparation Thereof And The Use As Pharmaceutical Composition
      摘要:(R)-2-(4-氨基苯胺甲基)-1-甲基-5-[1-(羧甲基氨基)-1-(吡咯烷基甲酰基)乙基]-苯并咪唑及其单盐酸盐的晶体形式,其制备方法以及用作药物组成物的用途.

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Remko M, Remková A, Broer R. Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors. Molecules. 2016 Feb 4;21(2). pii: E185. doi: 10.3390/molecules21020185. doi: 10.4103/0022-3859.105448. Review. doi: 10.1177/1753944710387808. Review.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知